BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Nov. 6, 2024
Though
the
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
is
no
more
of
a
public
health
emergency,
experiences
from
burying
SARS-CoV-2
infectious
dead
bodies
may
remain
with
workers.
For
Environmental
Health
Officers
(EHOs),
dealing
decedents
during
outbreak
arouse
strong
feelings
pity,
horror,
repulsion,
disgust,
and
anger
at
tragedy.
Therefore,
this
study
aims
to
explore
EHOs
in
disposing
off
confirmed
or
suspected
fatalities
Ghana.
Using
an
18-item
interview
guide,
we
gathered
data
27
three
regions
We
followed
steps
Descriptive
Phenomenology
conducting
analysis.
i.
were
confronted
several
occupational
safety
(OHS)
hazards
like
physical
chemical
injuries,
threat
harm,
psychological
ii.
The
officers
also
faced
severe
shortage
personal
protective
equipment
(PPE).
Unfortunately,
they
not
provided
any
form
support
period.
Ghana
exposed
major
fault
lines
safety/disaster
emergency
preparedness
towards
burial
disease
bodies.
Clearly,
disposal
exercise
failed
uphold
Sustainable
Development
Goals
(SDGs)
4.4,
8.3,
8.5,
which
advocate
for
promotion
decent
jobs
all.
Ghana's
Ministries
Health,
Local
Government,
Sanitation
Water
Resources
need
attach
Clinical
Psychologists
security
personnel
teams
future
exercises
provide
team.
studies
on
Africa
exist,
very
little
known
about
outbreak.
Biomolecules,
Journal Year:
2025,
Volume and Issue:
15(2), P. 280 - 280
Published: Feb. 14, 2025
Spike
protein
is
a
surface
glycoprotein
of
the
SARS-CoV-2
coronavirus,
providing
interaction
coronavirus
with
angiotensin-converting
enzyme
2
(ACE2)
on
host
cell.
The
cytoplasmic
tail
S
plays
an
important
role
in
intracellular
transport
and
translocation
to
plasma
membrane.
domain
contains
binding
sites
for
COPI,
COPII,
SNX27,
which
are
required
trafficking
this
glycoprotein.
In
addition,
S-palmitoylation
sites.
increases
hydrophobicity
by
regulating
its
has
signaling
sequence
that
provides
ERM
family
proteins,
may
mediate
communication
between
cell
membrane
actin
cytoskeleton.
This
review
examines
Understanding
these
processes
necessary
not
only
development
vaccines
based
mRNA
or
adenovirus
vectors
encoding
full-length
spike
(S)
protein,
but
also
therapy
new
infection
(COVID-19).
Molecules,
Journal Year:
2025,
Volume and Issue:
30(7), P. 1419 - 1419
Published: March 22, 2025
Introduction:
Currently,
there
are
no
effective
medications
for
treating
all
the
clinical
conditions
of
patients
with
COVID-19.
We
aimed
to
evaluate
antiviral
activity
compounds
derived
from
L-tyrosine
against
B.1
lineage
SARS-CoV-2
in
vitro
and
silico.
Methodology:
The
cytotoxicities
15
halogenated
were
evaluated
Vero-E6
cells
by
MTT
assay.
was
using
four
strategies,
viral
quantification
performed
a
plaque
assay
qRT-PCR.
toxicity
ADMET
predictor
software.
affinity
these
or
cellular
proteins
stability
their
conformations
determined
docking
molecular
dynamics,
respectively.
Results:
TODC-3M,
TODI-2M,
YODC-3M
reduced
titer
>40%
inhibited
replication
RNA
without
significant
cytotoxicity.
In
silico
analyses
revealed
that
presented
low
binding
energies
between
−4.3
−5.2
Kcal/mol
three
(spike,
Mpro,
RdRp).
TODC-3M
most
stable
proteins.
Conclusions:
promising
YODC-3M,
which
toxicity,
potential
through
different
favorable
affinities
targets.
Therefore,
they
candidates
vivo
studies.
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 424 - 424
Published: April 17, 2025
Vaccination
has
been
instrumental
in
curbing
the
transmission
of
SARS-CoV-2
and
mitigating
severity
clinical
manifestations
associated
with
COVID-19.
Numerous
COVID-19
vaccines
have
developed
to
this
effect,
including
BioNTech-Pfizer
Moderna’s
mRNA
vaccines,
as
well
adenovirus
vector-based
such
Oxford–AstraZeneca.
However,
emergence
new
variants
subvariants
SARS-CoV-2,
characterized
by
enhanced
transmissibility
immune
evasion,
poses
significant
challenges
efficacy
current
vaccination
strategies.
In
review,
we
aim
comprehensively
outline
landscape
emerging
concern
(VOCs)
sub-lineages
that
recently
surfaced
post-pandemic
years.
We
assess
effectiveness
existing
their
booster
doses,
against
these
subvariants,
BA.2-derived
sub-lineages,
XBB
BA.2.86
(Pirola).
Furthermore,
discuss
latest
advancements
vaccine
technology,
multivalent
pan-coronavirus
approaches,
along
development
several
next-generation
coronavirus
exosome-based,
virus-like
particle
(VLP),
mucosal,
nanomaterial-based
vaccines.
Finally,
highlight
key
critical
areas
for
future
research
address
evolving
threat
develop
strategies
combating
viral
threats,
thereby
improving
preparedness
pandemics.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(10), P. 1193 - 1193
Published: Oct. 19, 2024
Myocarditis
after
the
COVID-19
vaccine
is
one
of
important
adverse
events
following
immunization,
observed
mainly
mRNA-based
vaccines.
Importantly,
post-vaccination
myocarditis
was
less
common
than
SARS-CoV-2
infection,
as
it
scored
at
19.7
per
1,000,000
doses
and
2.76
1000
infections.
Predominantly,
its
course
benign
and,
compared
with
significantly
fewer
patients
developed
heart
failure
or
died
among
myocarditis.
The
group
highest
risk
related
to
vaccination
were
young
males
who
received
a
second
dose
an
mRNA
vaccine.
It
that,
vaccines,
specifically
mRNA-1273
associated
higher
mechanism
underlying
still
under
investigation
certain
processes
are
being
considered.
Currently,
some
follow-up
assessments
vaccine-induced
available
suggest
favorable
prognosis.
aim
this
review
discuss
most
recent
data
on
considering
epidemiology,
clinical
presentation,
diagnosis,
management,
relative
potential
mechanism,
We
present
a
case
study
of
34-year-old
male
who
was
in
good
health
prior
to
his
COVID-19
mRNA
vaccination.
Sixteen
days
after
first
dose,
he
experienced
acute
inflammation,
sudden
thoracic
aortic
dissection,
and
pericardial
tamponade,
rapidly
leading
death.
Studies
suggest
that
young
males,
particular,
appear
be
at
increased
risk
adverse
cardiac
events
following
Although
the
incidence
such
complications
are
believed
low,
we
propose
information
gaps
exist
criteria
findings
inform
both
public
agencies
on
rates
even
severe
myocarditis
This
view
is
shared
within
many
vaccine
studies
evident
this
Myocarditis,
Pericarditis,
Fatal
Aortic
Dissection
presented
here.